Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 02-2012 | 12-2011 | 11-2011 | 09-2011 | 08-2011 | |
| Operating Expenses | 940 | 0 | 466 | 0 | 0 |
| Operating Income | -940 | N/A | -466 | N/A | N/A |
| Interest Expense | 10 | 0 | 20 | 0 | 0 |
| Other Income | -36 | 0 | 7 | 0 | 0 |
| Pre-tax Income | -985 | 0 | -479 | 0 | 0 |
| Net Income Continuous | -985 | N/A | -479 | N/A | N/A |
| Net Income | $-985 | $N/A | $-479 | $N/A | $N/A |
| EPS Basic Total Ops | -0.17 | N/A | -0.01 | N/A | N/A |
| EPS Basic Continuous Ops | -0.17 | N/A | -0.01 | N/A | N/A |
| EPS Diluted Total Ops | -0.17 | N/A | -0.01 | N/A | N/A |
| EPS Diluted Continuous Ops | -0.17 | N/A | -0.01 | N/A | N/A |
| EBITDA(a) | $-929 | $N/A | $-460 | $N/A | $N/A |